Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace?
Hernandez
Adrian F
AF
Duke Clinical Research Institute and the Division of Cardiovascular Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA. adrian.hernandez@duke.edu
Harrington
Robert A
RA
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002170:Canada / Q000453:epidemiology; D019992:Databases as Topic; D019317:Evidence-Based Medicine; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D008297:Male; D017257:Ramipril / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000806:Angiotensin-Converting Enzyme Inhibitors; D017257:Ramipril